151 related articles for article (PubMed ID: 27691783)
21. Interrogation of the Substrate Profile and Catalytic Properties of the Phosphotriesterase from Sphingobium sp. Strain TCM1: An Enzyme Capable of Hydrolyzing Organophosphate Flame Retardants and Plasticizers.
Xiang DF; Bigley AN; Ren Z; Xue H; Hull KG; Romo D; Raushel FM
Biochemistry; 2015 Dec; 54(51):7539-49. PubMed ID: 26629649
[TBL] [Abstract][Full Text] [Related]
22. Molecular dynamics investigation on a series of HIV protease inhibitors: assessing the performance of MM-PBSA and MM-GBSA approaches.
Srivastava HK; Sastry GN
J Chem Inf Model; 2012 Nov; 52(11):3088-98. PubMed ID: 23121465
[TBL] [Abstract][Full Text] [Related]
23. Assessing the performance of the MM/PBSA and MM/GBSA methods. 10. Impacts of enhanced sampling and variable dielectric model on protein-protein Interactions.
Wang E; Weng G; Sun H; Du H; Zhu F; Chen F; Wang Z; Hou T
Phys Chem Chem Phys; 2019 Sep; 21(35):18958-18969. PubMed ID: 31453590
[TBL] [Abstract][Full Text] [Related]
24. Molecular dynamics simulations of the detoxification of paraoxon catalyzed by phosphotriesterase.
Zhang X; Wu R; Song L; Lin Y; Lin M; Cao Z; Wu W; Mo Y
J Comput Chem; 2009 Nov; 30(15):2388-401. PubMed ID: 19353598
[TBL] [Abstract][Full Text] [Related]
25. Enzymatic neutralization of the chemical warfare agent VX: evolution of phosphotriesterase for phosphorothiolate hydrolysis.
Bigley AN; Xu C; Henderson TJ; Harvey SP; Raushel FM
J Am Chem Soc; 2013 Jul; 135(28):10426-32. PubMed ID: 23789980
[TBL] [Abstract][Full Text] [Related]
26. Enzymatic resolution of chiral phosphinate esters.
Li Y; Aubert SD; Maes EG; Raushel FM
J Am Chem Soc; 2004 Jul; 126(29):8888-9. PubMed ID: 15264807
[TBL] [Abstract][Full Text] [Related]
27. QM/MM and MM MD simulations on decontamination of the V-type nerve agent VX by phosphotriesterase: toward a comprehensive understanding of steroselectivity and activity.
Fan F; Zheng Y; Fu Y; Zhang Y; Zheng H; Lyu C; Chen L; Huang J; Cao Z
Phys Chem Chem Phys; 2022 May; 24(18):10933-10943. PubMed ID: 35466335
[TBL] [Abstract][Full Text] [Related]
28. Phosphotriesterase variants with high methylphosphonatase activity and strong negative trade-off against phosphotriesters.
Briseño-Roa L; Timperley CM; Griffiths AD; Fersht AR
Protein Eng Des Sel; 2011 Jan; 24(1-2):151-9. PubMed ID: 21037279
[TBL] [Abstract][Full Text] [Related]
29. Overcoming the Challenges of Enzyme Evolution To Adapt Phosphotriesterase for V-Agent Decontamination.
Bigley AN; Desormeaux E; Xiang DF; Bae SY; Harvey SP; Raushel FM
Biochemistry; 2019 Apr; 58(15):2039-2053. PubMed ID: 30893549
[TBL] [Abstract][Full Text] [Related]
30. Theoretical study of the phosphotriesterase reaction mechanism.
Chen SL; Fang WH; Himo F
J Phys Chem B; 2007 Feb; 111(6):1253-5. PubMed ID: 17253743
[TBL] [Abstract][Full Text] [Related]
31. Update on biochemical properties of recombinant Pseudomonas diminuta phosphotriesterase.
Carletti E; Jacquamet L; Loiodice M; Rochu D; Masson P; Nachon F
J Enzyme Inhib Med Chem; 2009 Aug; 24(4):1045-55. PubMed ID: 19548794
[TBL] [Abstract][Full Text] [Related]
32. Catalytic efficiencies of directly evolved phosphotriesterase variants with structurally different organophosphorus compounds in vitro.
Goldsmith M; Eckstein S; Ashani Y; Greisen P; Leader H; Sussman JL; Aggarwal N; Ovchinnikov S; Tawfik DS; Baker D; Thiermann H; Worek F
Arch Toxicol; 2016 Nov; 90(11):2711-2724. PubMed ID: 26612364
[TBL] [Abstract][Full Text] [Related]
33. Assessing the performance of the molecular mechanics/Poisson Boltzmann surface area and molecular mechanics/generalized Born surface area methods. II. The accuracy of ranking poses generated from docking.
Hou T; Wang J; Li Y; Wang W
J Comput Chem; 2011 Apr; 32(5):866-77. PubMed ID: 20949517
[TBL] [Abstract][Full Text] [Related]
34. Assessing the performance of MM/PBSA and MM/GBSA methods. 3. The impact of force fields and ligand charge models.
Xu L; Sun H; Li Y; Wang J; Hou T
J Phys Chem B; 2013 Jul; 117(28):8408-21. PubMed ID: 23789789
[TBL] [Abstract][Full Text] [Related]
35. Enzyme-Catalyzed Kinetic Resolution of Chiral Precursors to Antiviral Prodrugs.
Xiang DF; Bigley AN; Desormeaux E; Narindoshvili T; Raushel FM
Biochemistry; 2019 Jul; 58(29):3204-3211. PubMed ID: 31268686
[TBL] [Abstract][Full Text] [Related]
36. Degradation of pesticides diazinon and diazoxon by phosphotriesterase: insight into divergent mechanisms from QM/MM and MD simulations.
Fu Y; Zhang Y; Fan F; Wang B; Cao Z
Phys Chem Chem Phys; 2022 Jan; 24(2):687-696. PubMed ID: 34927643
[TBL] [Abstract][Full Text] [Related]
37. Stereoselective hydrolysis of organophosphate nerve agents by the bacterial phosphotriesterase.
Tsai PC; Bigley A; Li Y; Ghanem E; Cadieux CL; Kasten SA; Reeves TE; Cerasoli DM; Raushel FM
Biochemistry; 2010 Sep; 49(37):7978-87. PubMed ID: 20701311
[TBL] [Abstract][Full Text] [Related]
38. Assessing the performance of MM/PBSA and MM/GBSA methods. 9. Prediction reliability of binding affinities and binding poses for protein-peptide complexes.
Weng G; Wang E; Chen F; Sun H; Wang Z; Hou T
Phys Chem Chem Phys; 2019 May; 21(19):10135-10145. PubMed ID: 31062799
[TBL] [Abstract][Full Text] [Related]
39. End-Point Binding Free Energy Calculation with MM/PBSA and MM/GBSA: Strategies and Applications in Drug Design.
Wang E; Sun H; Wang J; Wang Z; Liu H; Zhang JZH; Hou T
Chem Rev; 2019 Aug; 119(16):9478-9508. PubMed ID: 31244000
[TBL] [Abstract][Full Text] [Related]
40. Sulfhydryl-specific PEGylation of phosphotriesterase cysteine mutants for organophosphate detoxification.
Daffu GK; Lopez P; Katz F; Vinogradov M; Zhan CG; Landry DW; Macdonald J
Protein Eng Des Sel; 2015 Nov; 28(11):501-6. PubMed ID: 26243887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
